Shradheya R. Gupta
Faridabad, HR 121004, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
ROR1 protein: a pseudokinase at the crossroads of cancer progression and therapy.
Journal: Molecular biology reports
Published: October 06, 2025
Structure-based discovery of novel ROCK2 inhibitors using integrated virtual screening, molecular dynamics, metadynamics and absolute binding free energy calculations.
Journal: In silico pharmacology
Published: August 13, 2025
In silico identification and characterization of potential allergenic proteins from Vigna mungo (blackgram).
Journal: Journal of biomolecular structure & dynamics
Published: June 16, 2025
Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations.
Journal: Journal of molecular modeling
Published: May 30, 2025
Novel macromolecule CPD4 suppresses cell proliferation and metastasis of triple-negative breast cancer by targeting ROR1 protein.
Journal: International journal of biological macromolecules
Published: February 25, 2025
SARS-CoV-2 pathophysiology and post-vaccination severity: a systematic review.
Journal: Immunologic research
Published: October 17, 2024
Unlocking the Door for Precision Medicine in Rare Conditions: Structural and Functional Consequences of Missense ACVR1 Variants.
Journal: Omics : a journal of integrative biology
Published: September 17, 2024
Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer.
Journal: Journal of biomolecular structure & dynamics
Published: October 14, 2023
Deciphering mitogen activated protein kinase pathway activated during insect attack in Nicotiana attenuata.
Journal: Journal of biomolecular structure & dynamics
Published: October 09, 2023
PepAnalyzer: predicting peptide properties using its sequence.
Journal: Amino acids
Published: July 06, 2023
Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer.
Journal: Frontiers in cell and developmental biology
Published: June 21, 2023
Last Updated: 09/26/2026